RecruitingNot ApplicableNCT07749820

Clinical Trial of Thrombectomy Systems

A Prospective, Multicenter, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Thrombectomy Systems for the Treatment of Lower Extremity Deep Vein Thrombosis


Sponsor

BrosMed Medical Co., Ltd

Enrollment

167 participants

Start Date

Aug 30, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study plans to enroll 167 subjects. Subject enrollment and treatment details will be documented, and follow-up assessments will be conducted at screening, on the procedure day, before discharge, and at 1, 3, and 6 months after the procedure, to assess the safety and efficacy of the peripheral thrombectomy system for the treatment of lower extremity deep vein thrombosis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Peripheral thrombectomy system for people with deep vein thrombosis (dvt). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPeripheral thrombectomy system

For the subjects who met the requirements of the study protocol, the BM peripheral thrombectomy system was used for treatment.


Locations(1)

Zhongshan Hospital, Fudan University

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07749820


Related Trials